Appel à projets : PHRCK (2015)
Titre : NANOCOL- A multicenter Phase I study evaluating the safety of AGuIX gadolinium-based nanoparticles in locally advanced cervical carcinoma - a strategy based on theranostic optimization
Acronyme : NANOCOL
Discipline principale : Cancer
Porteur : Cyrus CHARGARI
Établissement : INSTITUT GUSTAVE ROUSSY (CLCC), Île-de-France
Financement total : 310437 €